AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Savonix Names Jillian Kwan-Jacobs New Chief Operating Officer

October 14, 2019

SAN FRANCISCO--(BUSINESS WIRE)--Oct 14, 2019--

Savonix, a global leader in digital tests for cognitive health, today announced the appointment of Jillian Kwan-Jacobs as Chief Operating Officer effective October 18, 2019. She will be a key member of the executive management team, reporting directly to Dr. Mylea Charvat, CEO & Founder, Savonix.

As COO, Kwan-Jacobs will be responsible for strategic oversight for Finance, Global and US Operations and services organizations and will work with the broader executive team to drive accountability to operational goals across Savonix. She will be responsible for the alignment and prioritization of company initiatives to ensure Savonix’s continued growth and operational excellence.

Kwan-Jacobs brings more than 18 years of extensive experience in operations strategy development, management consulting and financial analysis from healthcare and financial services. She was most recently Director of Operations at Sutter Health | Aetna, an innovative health plan serving the Northern California market. Prior to that, she was Director of Operations overseeing business functions globally at Sensely Corporation, a digital health startup, and Senior Manager of National Strategy and Implementation for the clinical laboratories across Kaiser Permanente. She has also held numerous positions in the finance industry, including Morgan Stanley, Merrill Lynch, and Fisher Investments.

“We are excited to welcome Kwan-Jacobs to the Savonix team. In her new role, she will drive integration and innovation for global operations, allowing Savonix to accelerate our vision and build on our current strategy and product offerings in the digital cognitive assessment market,” said Dr. Mylea Charvat, CEO & Founder, Savonix.

“I was drawn to Savonix’s leadership in brain health, as well as their care model, which drives a deeply meaningful and lasting impact in the lives of patients and their families. I’m thrilled to be joining Savonix to transform cognitive testing and clinical outcomes at a growing scale,” said Kwan-Jacobs. “Savonix is passionate about their mission and values, and it is an honor to be a part of a team that is dedicated to creating a world without dementia.”

Kwan-Jacobs received her MBA with concentrations in Healthcare Management and Global Management from the Haas School of Business, UC Berkeley and her BA in Mass Communications from University of California at Berkeley.

About Savonix

Savonix delivers a fully mobile assessment of cognitive function available on Android and iOS for phone and tablet, the Savonix Cognitive Assessment platform is an accurate, accessible and affordable tool for professional cognitive screens. It empowers healthcare providers, payers and researchers to evaluate and leverage results to improve health and treatment outcomes. Led by clinical neuropsychologists and digital health technology experts, the company has established itself as an authority on cognition globally. To learn more about Savonix, visit Savonix.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191014005008/en/

CONTACT: Media:

Kimberly Ha

KKH Advisors

kimberly.ha@kkhadvisors.com

917-291-5744

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: BIOTECHNOLOGY MOBILE/WIRELESS TECHNOLOGY HEALTH OTHER HEALTH OTHER SCIENCE RESEARCH TELECOMMUNICATIONS GENERAL HEALTH SCIENCE

SOURCE: Savonix

Copyright Business Wire 2019.

PUB: 10/14/2019 08:30 AM/DISC: 10/14/2019 08:30 AM

http://www.businesswire.com/news/home/20191014005008/en